Patents by Inventor Martin Koser

Martin Koser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230000895
    Abstract: This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections.
    Type: Application
    Filed: February 2, 2022
    Publication date: January 5, 2023
    Inventors: Martin KOSER, Marc ABRAMS
  • Patent number: 11273173
    Abstract: This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections.
    Type: Grant
    Filed: May 12, 2021
    Date of Patent: March 15, 2022
    Assignee: Dicerna Pharmaceuticals, Inc.
    Inventors: Martin Koser, Marc Abrams
  • Publication number: 20210283164
    Abstract: This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections.
    Type: Application
    Filed: May 12, 2021
    Publication date: September 16, 2021
    Inventors: Martin KOSER, Marc ABRAMS
  • Patent number: 11052104
    Abstract: This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections.
    Type: Grant
    Filed: July 7, 2020
    Date of Patent: July 6, 2021
    Assignee: Dicerna Pharmaceuticals, Inc.
    Inventors: Martin Koser, Marc Abrams
  • Patent number: 11052105
    Abstract: This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections.
    Type: Grant
    Filed: July 7, 2020
    Date of Patent: July 6, 2021
    Assignee: Dicerna Pharmaceuticals, Inc.
    Inventors: Martin Koser, Marc Abrams
  • Publication number: 20200338108
    Abstract: This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections.
    Type: Application
    Filed: July 7, 2020
    Publication date: October 29, 2020
    Inventors: Martin KOSER, Marc ABRAMS
  • Publication number: 20200338109
    Abstract: This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections.
    Type: Application
    Filed: July 7, 2020
    Publication date: October 29, 2020
    Inventors: Martin KOSER, Marc ABRAMS
  • Patent number: 10799524
    Abstract: This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: October 13, 2020
    Assignee: Dicerna Pharmaceuticals, Inc.
    Inventors: Martin Koser, Marc Abrams
  • Publication number: 20200171069
    Abstract: This application relates to potent oligonucleotides useful for reducing HBsAg expression and treating HBV infections.
    Type: Application
    Filed: February 14, 2020
    Publication date: June 4, 2020
    Inventors: Martin Koser, Marc Abrams